523 related articles for article (PubMed ID: 32745100)
21. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
[TBL] [Abstract][Full Text] [Related]
22. Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia.
Abrha S; Tadesse E; Atey TM; Molla F; Melkam W; Masresha B; Gashaw S; Wondimu A
BMC Pregnancy Childbirth; 2018 Nov; 18(1):464. PubMed ID: 30497441
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
Osuafor NG; Ukwe CV; Okonta M
PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
[TBL] [Abstract][Full Text] [Related]
24. Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?
Bertoldi AD; Helfer AP; Camargo AL; Tavares NU; Kanavos P
Global Health; 2012 Mar; 8():6. PubMed ID: 22436555
[TBL] [Abstract][Full Text] [Related]
25. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
[TBL] [Abstract][Full Text] [Related]
26. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria.
Orubu ESF; Robert FO; Samuel M; Megbule D
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074
[TBL] [Abstract][Full Text] [Related]
27. Availability, pricing and affordability of selected medicines for noncommunicable diseases.
Heidari E; Varmaghani M; Abdollahiasl A
East Mediterr Health J; 2019 Oct; 25(7):473-480. PubMed ID: 31612979
[TBL] [Abstract][Full Text] [Related]
28. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
Dabare PR; Wanigatunge CA; Beneragama BH
BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
[TBL] [Abstract][Full Text] [Related]
29. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
30. The prices people pay for medicines in Zimbabwe.
Gavaza P; Simoyi T; Makunike B; Maponga CC
Cent Afr J Med; 2009; 55(1-4):14-9. PubMed ID: 21977842
[TBL] [Abstract][Full Text] [Related]
31. Medicine prices, availability, and affordability in the Shaanxi Province in China: implications for the future.
Jiang M; Zhou Z; Wu L; Shen Q; Lv B; Wang X; Yang S; Fang Y
Int J Clin Pharm; 2015 Feb; 37(1):12-7. PubMed ID: 25425142
[TBL] [Abstract][Full Text] [Related]
32. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.
Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D
Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028
[TBL] [Abstract][Full Text] [Related]
33. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China.
Liu C; Zhang X; Liu C; Ewen M; Zhang Z; Liu G
BMC Health Serv Res; 2017 Aug; 17(1):597. PubMed ID: 28836974
[TBL] [Abstract][Full Text] [Related]
34. Assessment of prices, availability and affordability of essential medicines in Juba County, South Sudan.
Deng J; Mayai AT; Kayitare E; Ntakirutimana T; Swallehe O; Bizimana T
J Pharm Policy Pract; 2023 Dec; 16(1):172. PubMed ID: 38158563
[TBL] [Abstract][Full Text] [Related]
35. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.
Todesco B; Ostuzzi G; Barbui C
Epidemiol Psychiatr Sci; 2022 Apr; 31():e22. PubMed ID: 35438063
[TBL] [Abstract][Full Text] [Related]
36. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
Sado E; Sufa A
BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
[TBL] [Abstract][Full Text] [Related]
37. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana.
Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F
BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117
[TBL] [Abstract][Full Text] [Related]
38. Prices, Availability and Affordability of Medicines with Value-Added Tax Exemption: A Cross-Sectional Survey in the Philippines.
Lambojon K; Chang J; Saeed A; Hayat K; Li P; Jiang M; Atif N; Desalegn GK; Khan FU; Fang Y
Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32708060
[TBL] [Abstract][Full Text] [Related]
39. A survey of the availability, prices and affordability of essential medicines in Jiangsu Province, China.
Xi X; Li W; Li J; Zhu X; Fu C; Wei X; Chu S
BMC Health Serv Res; 2015 Aug; 15():345. PubMed ID: 26310243
[TBL] [Abstract][Full Text] [Related]
40. Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Yang C; Jiang M; Zhao M; Ji W; Aziz MM; Khan FU; Gillani AH; Atif N; Fang Y; Babar ZUD
BMJ Open; 2020 Oct; 10(10):e034720. PubMed ID: 33033079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
